ZA200401887B - Substituted benzimidazole compounds and their use for the treatment of cancer. - Google Patents

Substituted benzimidazole compounds and their use for the treatment of cancer. Download PDF

Info

Publication number
ZA200401887B
ZA200401887B ZA200401887A ZA200401887A ZA200401887B ZA 200401887 B ZA200401887 B ZA 200401887B ZA 200401887 A ZA200401887 A ZA 200401887A ZA 200401887 A ZA200401887 A ZA 200401887A ZA 200401887 B ZA200401887 B ZA 200401887B
Authority
ZA
South Africa
Prior art keywords
benzoimidazol
ester
benzenesulfonic acid
amino
ureido
Prior art date
Application number
ZA200401887A
Other languages
English (en)
Inventor
Francois Clerc
Isabelle Depaty
Stephanie Deprets
Manfred Roesner
Francois Hamy
Odile Angouillant-Boniface
Chantal Carrez
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of ZA200401887B publication Critical patent/ZA200401887B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200401887A 2001-09-26 2004-03-08 Substituted benzimidazole compounds and their use for the treatment of cancer. ZA200401887B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01402460A EP1298125A1 (de) 2001-09-26 2001-09-26 Substituierte Benzimidazolverbindungen und ihre Verwendung zur Behandlung von Krebs

Publications (1)

Publication Number Publication Date
ZA200401887B true ZA200401887B (en) 2005-05-31

Family

ID=8182891

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200401887A ZA200401887B (en) 2001-09-26 2004-03-08 Substituted benzimidazole compounds and their use for the treatment of cancer.

Country Status (35)

Country Link
US (1) US7041668B2 (de)
EP (2) EP1298125A1 (de)
JP (1) JP4510450B2 (de)
KR (1) KR100891439B1 (de)
CN (1) CN100346786C (de)
AR (1) AR037096A1 (de)
AT (1) ATE386517T1 (de)
AU (1) AU2002337151B2 (de)
BR (1) BR0212856A (de)
CA (1) CA2461622C (de)
CO (1) CO5570675A2 (de)
CY (1) CY1107953T1 (de)
DE (1) DE60225159T2 (de)
DK (1) DK1432417T3 (de)
EA (1) EA006802B1 (de)
ES (1) ES2301682T3 (de)
GT (1) GT200200190A (de)
HR (1) HRPK20040293B3 (de)
HU (1) HUP0401756A3 (de)
IL (1) IL161059A0 (de)
ME (1) MEP16808A (de)
MX (1) MXPA04002042A (de)
MY (1) MY135339A (de)
NO (1) NO327008B1 (de)
NZ (1) NZ531246A (de)
PA (1) PA8555501A1 (de)
PE (1) PE20030427A1 (de)
PL (1) PL369527A1 (de)
PT (1) PT1432417E (de)
PY (1) PY0223362A (de)
RS (1) RS50896B (de)
SI (1) SI1432417T1 (de)
UY (1) UY27452A1 (de)
WO (1) WO2003028721A2 (de)
ZA (1) ZA200401887B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
AU2011250847B2 (en) * 2003-06-23 2013-06-20 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
EP1678121A4 (de) * 2003-10-24 2007-07-25 Exelixis Inc Modulatoren von tao-kinase und anwendungsverfahren
DE102004010207A1 (de) 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
FR2868421B1 (fr) * 2004-04-01 2008-08-01 Aventis Pharma Sa Nouveaux benzothiazoles et leur utilisation comme medicaments
EP1598348A1 (de) 2004-05-18 2005-11-23 Aventis Pharma Deutschland GmbH Pyridazinonderivate als CDK2-Inhibitoren
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
UA92180C2 (en) * 2005-09-06 2010-10-11 Смиткляйн Бичам Корпорейшн Benzimidazole thiophene compounds as plk inhibitors
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
PT2089417E (pt) 2006-10-12 2015-04-14 Bhi Ltd Partnership Métodos, compostos, composições e veículos para administrar o ácido 3-amino-1-propanossulfónico
PA8792501A1 (es) 2007-08-09 2009-04-23 Sanofi Aventis Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
SG185297A1 (en) * 2007-10-12 2012-11-29 Abbott Lab 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
FR2922550B1 (fr) 2007-10-19 2009-11-27 Sanofi Aventis Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet
FR2941951B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-nh-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941952B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-substitue-triazolopyridazine-sulfanyl) 5-fluoro-benzothiazoles et 5-fluoro-benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941949B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-cycloalkyl ou 6-nh-cycloalkyl- triazolopyridazine-sulfanyl)benzothiazoles et benzimidazoles preparation, application comme medicaments et utilisation comme inhibiteurs de met.
FR2941950B1 (fr) 2009-02-06 2011-04-01 Sanofi Aventis Derives de 6-(6-o-substitue-triazolopyridazine-sulfanyl) benzothiazoles et benzimidazoles : preparation, application comme medicaments et utilisation comme inhibiteurs de met.
WO2011091152A1 (en) * 2010-01-22 2011-07-28 Pablo Gastaminza Inhibitors of hepatitis c virus infection
US10125369B2 (en) 2012-12-05 2018-11-13 Alnylam Pharmaceuticals, Inc. PCSK9 iRNA compositions and methods of use thereof
CN118697894A (zh) 2015-08-25 2024-09-27 阿尔尼拉姆医药品有限公司 用于治疗前蛋白转化酶枯草杆菌蛋白酶kexin(pcsk9)基因相关障碍的方法和组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2441201C2 (de) * 1974-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Anthelminthisch wirksame 2-Carbalkoxyamino-5(6)-phenyl-sulfonyloxy-benzimidazole und Verfahren zu ihrer Herstellung
DE2541752A1 (de) 1975-09-19 1977-03-24 Hoechst Ag Anthelminthisch wirksame 2-carbalkoxyamino-5(6)-phenyl-sulfonyloxy- benzimidazole und verfahren zu ihrer herstellung
DE3247615A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB9900752D0 (en) * 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
US6693125B2 (en) * 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders

Also Published As

Publication number Publication date
GT200200190A (es) 2003-11-11
EP1298125A1 (de) 2003-04-02
DE60225159T2 (de) 2009-02-19
CN1558761A (zh) 2004-12-29
CY1107953T1 (el) 2013-09-04
EA006802B1 (ru) 2006-04-28
AR037096A1 (es) 2004-10-20
PY0223362A (es) 2004-04-01
BR0212856A (pt) 2004-09-14
CA2461622A1 (en) 2003-04-10
JP4510450B2 (ja) 2010-07-21
US7041668B2 (en) 2006-05-09
CA2461622C (en) 2008-12-02
CO5570675A2 (es) 2005-10-31
KR20040048904A (ko) 2004-06-10
MY135339A (en) 2008-03-31
YU21404A (sh) 2006-08-17
WO2003028721A3 (en) 2003-12-11
NZ531246A (en) 2006-06-30
ATE386517T1 (de) 2008-03-15
PT1432417E (pt) 2008-05-23
WO2003028721A2 (en) 2003-04-10
AU2002337151B2 (en) 2007-04-26
HRPK20040293B3 (hr) 2007-06-30
HUP0401756A2 (hu) 2005-01-28
RS50896B (sr) 2010-08-31
DK1432417T3 (da) 2008-06-16
EA200400475A1 (ru) 2004-08-26
DE60225159D1 (de) 2008-04-03
PL369527A1 (en) 2005-05-02
IL161059A0 (en) 2004-08-31
PA8555501A1 (es) 2003-06-30
PE20030427A1 (es) 2003-06-20
MEP16808A (bs) 2010-06-10
EP1432417B1 (de) 2008-02-20
US20050014811A1 (en) 2005-01-20
CN100346786C (zh) 2007-11-07
HUP0401756A3 (en) 2005-06-28
EP1432417A2 (de) 2004-06-30
HRP20040293A2 (en) 2005-06-30
NO20041214L (no) 2004-06-24
KR100891439B1 (ko) 2009-04-03
UY27452A1 (es) 2003-02-28
JP2005504112A (ja) 2005-02-10
ES2301682T3 (es) 2008-07-01
NO327008B1 (no) 2009-04-06
SI1432417T1 (sl) 2008-08-31
MXPA04002042A (es) 2004-06-07
HK1068551A1 (en) 2005-04-29

Similar Documents

Publication Publication Date Title
ZA200401887B (en) Substituted benzimidazole compounds and their use for the treatment of cancer.
EP2451794B1 (de) 1,2,4-thiazolidin-3-on- derivate und ihre verwendung in der behandlung von krebs
CA2684470C (en) Pyrimidine derivatives
KR101837759B1 (ko) 치환된 융합 이미다졸 유도체, 약학적 조성물, 및 그것의 사용 방법
AU2002337151A1 (en) Substituted benzimidazole compounds and their use for the treatment of cancer
CZ297451B6 (cs) Derivát cyklického diaminu, jeho pouzití a farmaceutický prostredek, který ho obsahuje
EP2310366A2 (de) Neue triazolo(4,3-a)pyridinderivate, verfahren zu deren herstellung, deren verwendung als medikamente, pharmazeutische zusammensetzungen und neue anwendung, insbesondere als met-inhibitoren
IL301568A (en) Protein alpha kinase 1 inhibitors and methods of use
US20040167187A1 (en) Sulfhydantoins as phosphate isosteres
AU2006331656B2 (en) Calcium channel antagonists
AU2006243328A1 (en) Urea derivatives methods for their manufacture and uses thereof
KR20070007885A (ko) 신규한 벤조티아졸 및 의약으로서의 그의 용도
NZ566568A (en) Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors
RU2395501C2 (ru) Новые производные 2,4-диаминотиазол-5-она
AU2017444054A1 (en) Class of pyrimidine derivative kinase inhibitors
HK1170485B (en) 1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer
Wang et al. DOI: Reference
FR2941229A1 (fr) Nouveaux derives triazolo°4,3-a!pyridine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de met
HK1156612A (en) Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
MXPA06011160A (en) Novel benzothiazoles and the use thereof as medicaments